These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30261040)

  • 1. EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers.
    Pan M; Schinke H; Luxenburger E; Kranz G; Shakhtour J; Libl D; Huang Y; Gaber A; Pavšič M; Lenarčič B; Kitz J; Jakob M; Schwenk-Zieger S; Canis M; Hess J; Unger K; Baumeister P; Gires O
    PLoS Biol; 2018 Sep; 16(9):e2006624. PubMed ID: 30261040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma.
    Umemori K; Ono K; Eguchi T; Kawai H; Nakamura T; Ogawa T; Yoshida K; Kanemoto H; Sato K; Obata K; Ryumon S; Yutori H; Katase N; Okui T; Nagatsuka H; Ibaragi S
    Oral Oncol; 2023 Jul; 142():106433. PubMed ID: 37236125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway.
    Maseki S; Ijichi K; Tanaka H; Fujii M; Hasegawa Y; Ogawa T; Murakami S; Kondo E; Nakanishi H
    Br J Cancer; 2012 Mar; 106(6):1196-204. PubMed ID: 22315058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
    Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
    Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway.
    Wang Q; Liao C; Tan Z; Li X; Guan X; Li H; Tian Z; Liu J; An J
    Cancer Gene Ther; 2023 Jan; 30(1):182-191. PubMed ID: 36151332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
    Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
    Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma.
    Ingruber J; Savic D; Steinbichler TB; Sprung S; Fleischer F; Glueckert R; Schweigl G; Skvortsova II; Riechelmann H; Dudás J
    Cells; 2021 Mar; 10(3):. PubMed ID: 33802627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of GRB2-associated binder 1 in epidermal growth factor receptor-induced signaling in head and neck squamous cell carcinoma.
    Hoeben A; Martin D; Clement PM; Cools J; Gutkind JS
    Int J Cancer; 2013 Mar; 132(5):1042-50. PubMed ID: 22865653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.
    Brown TC; Sankpal NV; Gillanders WE
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway.
    Wu TK; Ou YC; Chen YP; Huang FM; Pan YR; Lee CJ
    Anticancer Res; 2021 Aug; 41(8):3789-3799. PubMed ID: 34281838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells.
    Liang KH; Tso HC; Hung SH; Kuan II; Lai JK; Ke FY; Chuang YT; Liu IJ; Wang YP; Chen RH; Wu HC
    Cancer Lett; 2018 Oct; 433():165-175. PubMed ID: 29981429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells.
    Tsai PC; Fu YS; Chang LS; Lin SR
    Toxicon; 2016 Mar; 111():108-20. PubMed ID: 26774845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
    Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
    PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].
    Yuki R
    Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
    Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
    Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells.
    Vergara D; Valente CM; Tinelli A; Siciliano C; Lorusso V; Acierno R; Giovinazzo G; Santino A; Storelli C; Maffia M
    Cancer Lett; 2011 Nov; 310(1):1-8. PubMed ID: 21794976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of Slug by NF-κB is Essential for TNF-α -Induced Migration and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cells.
    Liu S; Shi L; Wang Y; Ye D; Ju H; Ma H; Yang W; Wang Y; Hu J; Deng J; Zhang Z
    Cell Physiol Biochem; 2018; 47(2):567-578. PubMed ID: 29794474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition and stem cell-like properties in hepatocellular carcinoma cells.
    Lim WC; Kim H; Kim YJ; Jeon BN; Kang HB; Ko H
    Sci Rep; 2020 May; 10(1):7620. PubMed ID: 32376896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells.
    Jameson MJ; Beckler AD; Taniguchi LE; Allak A; Vanwagner LB; Lee NG; Thomsen WC; Hubbard MA; Thomas CY
    Mol Cancer Ther; 2011 Nov; 10(11):2124-34. PubMed ID: 21878657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.